Journal
TRENDS IN MICROBIOLOGY
Volume 29, Issue 6, Pages 473-476Publisher
CELL PRESS
DOI: 10.1016/j.tim.2020.12.009
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81772233, 81661130159, 81861138055]
- West China Hospital of Sichuan University (1.3.5 project for disciplines of excellence) [ZYYC08006, 312190022]
- Newton Advanced Fellowship, Royal Society, UK [NA150363]
- Medical Research Council [MR/S013660/1]
- MRC [MR/S013660/1] Funding Source: UKRI
Ask authors/readers for more resources
Enterobacter is a globally important pathogen with resistance to carbapenem and colistin. Further research is needed to understand colistin heteroresistance and the emergence of certain Enterobacter lineages clinically.
Enterobacter is a globally important pathogen. Here we clarify its taxonomy and review recent developments in its resistance to carbapenem and colistin, illustrating that Enterobacter has a large arsenal of mechanisms to grow under antimicrobial pressure. Further studies are required to decipher colistin heteroresistance and understand why certain Enterobacter lineages have emerged clinically.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
